Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics
September 19, 2024 07:12 ET
|
Tilray Brands, Inc.
Shock Top is proud to contribute to the collegiate experience by promoting a culture of inclusivity, support, and pride that transcends the game.
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Arqit Quantum Inc. Announces 25:1 Reverse Share Split
September 19, 2024 07:00 ET
|
Arqit
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a leader in quantum safe encryption, today announces that, following approval by the...
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
September 19, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
MoneyHero Group Reports Second Quarter 2024 Results
September 19, 2024 07:00 ET
|
MoneyHero Limited
MoneyHero Group Reports Second Quarter 2024 Results
Canoo’s Oklahoma City Manufacturing Facility Achieves Final Activation as First Automotive Foreign-Trade Zone in the State of Oklahoma
September 19, 2024 07:00 ET
|
Canoo, Inc.
Canoo’s Oklahoma City Manufacturing Facility Achieves Final Activation as First Automotive Foreign-Trade Zone in the State of Oklahoma
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
September 19, 2024 07:00 ET
|
ACELYRIN, INC.
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative...
Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson’s Disease Models Including Two Late-Breakers at Neuroscience 2024
September 19, 2024 07:00 ET
|
Gain Therapeutics, Inc.
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...
FactSet Reports Results for Fourth Quarter 2024
September 19, 2024 07:00 ET
|
FactSet Research Systems Inc.
Q4 GAAP revenues of $562.2 million, up 4.9% from Q4 2023.Organic Q4 ASV plus professional services of $2,272.8 million, up 4.8% year over year.Q4 GAAP operating margin of 22.7%, up approximately 110...
Plug Power Launches an Equipment Lease Financing Platform - Plug is Targeting >$150 million from a Combination of Debt Leverage & Customer Financing Solutions
September 19, 2024 07:00 ET
|
Plug Power, Inc.
SLINGERLANDS, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has announced the...